442 results
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
& Vasopressor Dosing ... Paralytic Agents ... (Depolarizing Agent ... vasopressors #paralytics #agents ... #pharmacology #dosing
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Assessment and Management ... Non-Opioid Analgesics - Agents ... and Dosing #Management ... Medications #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Assessment and Management ... Equianalgesic Chart - Agents ... and Dosing #Management ... Conversion #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Assessment and Management ... Muscle Relaxants - Agents ... and Dosing #Management ... Medications #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Assessment and Management ... Distribution, Agents ... and Dosing Table ... Ropivicaine (0.5%) #Management ... Medications #Doses #Dosing
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents ... #Pharmacology #Dosing ... #Dosing #Renal
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... Medications: Agent ... Nortriptyline #Management ... Medications #Doses #Dosing
Management of Jehovah's Witness patient in ICU 

Clarify which products may be used 
 - Discuss
Management of Jehovah's ... pro-actively upon admission ... most reversible agent ... of hemostatic agents ... #CriticalCare #Management
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
) - Vasculitis Management ... Severe Disease → Remission ... Non-Severe Disease → Remission ... immunosuppressive agent ... Nodosa #Vasculitis #Management
CURB-65 Scoring and Risk Stratification for Pneumonia - Admission Assessment

#Diagnosis #Management #Admission #Pneumonia #Risk #Stratification #CURB65
for Pneumonia - Admission ... #Diagnosis #Management ... #Admission #Pneumonia